The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 13, 2016

Filed:

Mar. 07, 2014
Applicant:

Sanofi, Paris, FR;

Inventors:

Werngard Czechtizky, Frankfurt am Main, DE;

John Weston, Frankfurt am Main, DE;

Nils Rackelmann, Frankfurt am Main, DE;

Volker Kraft, Frankfurt am Main, DE;

Petra Arndt, Frankfurt am Main, DE;

Klaus Wirth, Frankfurt am Main, DE;

Heinz Goegelein, Frankfurt am Main, DE;

Olaf Ritzeler, Frankfurt am Main, DE;

Assignee:

Sanofi, Paris, FR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 311/60 (2006.01); C07F 9/655 (2006.01); C07D 409/12 (2006.01); C07D 413/12 (2006.01); C07D 405/12 (2006.01); C07D 417/12 (2006.01); C07D 417/14 (2006.01); C07D 407/14 (2006.01); C07D 407/12 (2006.01);
U.S. Cl.
CPC ...
C07D 311/60 (2013.01); C07D 405/12 (2013.01); C07D 407/12 (2013.01); C07D 407/14 (2013.01); C07D 409/12 (2013.01); C07D 413/12 (2013.01); C07D 417/12 (2013.01); C07D 417/14 (2013.01); C07F 9/65522 (2013.01);
Abstract

The present invention relates to substituted chroman-6-yloxy-cycloalkanes of the formula (I) in which Ar, R1 to R4, p and q are as defined in the claims. The compounds of the formula (I) are inhibitors of the sodium-calcium exchanger (NCX), especially of the sodium-calcium exchanger of subtype 1 (NCX1), and are suitable for the treatment of diverse disorders in which intracellular calcium homeostasis is disturbed, such as arrhythmias, heart failure and stroke. The invention furthermore relates to processes for the preparation of the compounds of the formula (I), their use as pharmaceuticals, and pharmaceutical compositions comprising them.


Find Patent Forward Citations

Loading…